Rituximab in Neuromyelitis Optica Spectrum Disorders: Why Not as First-Line Therapy. [electronic resource]
Producer: 20181030Description: 482 p. digitalISSN:- 2168-6157
No physical items for this record
Publication Type: Journal Article; Comment
There are no comments on this title.
Log in to your account to post a comment.